Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Ushijima, Kimio; Yahata, Hideaki; Yoshikawa, Hiroyuki; Konishi, Ikuo; Yasugi, Toshiharu; Saito, Toshiaki; Nakanishi, Toru; Sasaki, Hiroshi; Saji, Fumitaka; Iwasaka, Tsuyoshi; Hatae, Masayuki; Kodama, Shoji; Saito, Tsuyoshi; Terakawa, Naoki; Yaegashi, Nobuo; Hiura, Masamichi; Sakamoto, Atsuhiko; Tsuda, Hitoshi; Fukunaga, Masaharu; Kamura, Toshiharu

doi:10.1200/jco.2006.08.8344

Public

Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Shared by NobleBlocks on Jul 1, 2007 • 12:00 AM UTC

Authors:

Kimio Ushijima

Hideaki Yahata

Hiroyuki Yoshikawa

Abstract

Purpose To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women. Patients and Methods This multicenter prospective study was carried out at 16 institutions in Japan. Twenty-e...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!